Glucocorticoid-dependent negative feedback of the hypothalamic-pituitary-adrenal axis is mediated in part through direct inhibition of hypothalamic CRH gene transcription. In the present study, we sought to further localize and characterize glucocorticoid receptor (GR) and AP-1 interactions at a functionally defined negative glucocorticoid response element (nGRE) of the CRH promoter. Transient transfection studies in mouse corticotroph AtT-20 cells demonstrated that internal deletion of the nGRE (؊278 to ؊249 nucleotides) within the context of 1 kb of the intact CRH promoter resulted in decreased 8-BrcAMP stimulation and glucocorticoid-dependent repression of CRH promoter activity. The nGRE conferred transcriptional activation by both cAMP and overexpressed c-jun or c-fos AP-1 nucleoproteins as well as specific glucocorticoid-dependent repression to a heterologous promoter. A similar profile of regulation was observed for the composite GRE derived from mouse proliferin promoter. The CRH nGRE was clearly distinct from the consensus cAMP response element (CRE) at ؊224 nucleotides, which increased basal activity and cAMP responsiveness of a heterologous promoter but did not confer glucocorticoid-dependent repression. High-affinity binding sites for both GR and AP-1 nucleoproteins were identified at adjacent elements within the nGRE. Mutations that disrupted either GR or AP-1 binding activity were associated with loss of glucocorticoid-dependent repression. These results are consistent with a composite mechanism of glucocorticoid-dependent repression involving direct DNA binding of GR and AP-1 nucleoproteins at discrete adjacent sites within the CRH promoter. (Molecular Endocrinology 13: 1629-1644, 1999)
INTRODUCTION
Hypothalamic CRH-producing neurons integrate afferent central nervous system signals related to stress responsiveness and circadian rhythmicity as well as negative feedback inhibition by glucocorticoids (1, 2). The primacy of CRH in central regulation of the hypothalamic-pituitary-adrenal (HPA) axis is established in animal and human models of CRH deficiency and excess. The CRH knockout mouse demonstrates low levels of ACTH and corticosterone and a blunted HPA response. Thus, even in the setting of reduced corticosteroid feedback, other ACTH secretagogues, such as vasopressin, are unable to compensate for CRH deficiency (3, 4) . Within the clinical model of Cushing's syndrome, the prolonged suppression of ACTH and cortisol secretion that remains after chronic corticosteroid excess can be reversed by administration of exogenous CRH, indicating that repression of central signals limits recovery of the HPA axis (5) .
Data suggest that hypothalamic CRH repression is mediated, in part, through direct effects on hypothalamic CRH-producing neurons (6, 7) , which express high levels of classical (type II) glucocorticoid receptor (GR) (8) . However, other sites of corticosteroid action may contribute to repression of hypothalamic CRH, as both GR and corticosteroid-responsive mineralocorticoid receptors are expressed in extrahypothalamic central nervous system sites (9, 10) . Glucocorticoids appear to regulate CRH through direct inhibition of gene transcription (11) . This effect is tissue specific; CRH mRNA levels are unaffected by glucocorticoids at several extrahypothalamic central nervous system sites (12, 13) and are paradoxically up-regulated by glucocorticoids in cultured human placental trophoblasts (14) .
In vitro studies suggest that glucocorticoids inhibit CRH gene transcription through specific sites within the CRH promoter (15) (16) (17) . Regulatory elements contained within the proximal 1 kb of the CRH promoter are necessary and sufficient to confer cAMP-dependent activation and glucocorticoid-dependent transcriptional regulation to the stably transfected CRH gene (18) or to CRH promoter-reporter constructs in transient transfection studies (15) (16) (17) . The cAMP response element (CRE, 5Ј-TGACGTCA-3Ј) centered at Ϫ224 nucleotide (nt) affects basal promoter activity as well as cAMP-dependent, 12-O-tetradecanoylphorbol-13-acetate-dependent, and depolarizationdependent transcriptional activation of the CRH promoter (19) (20) (21) . In contrast, localization and characterization of cis-acting elements mediating glucocorticoid-dependent repression within the CRH promoter and potential mechanisms involved in hormonal repression remain uncertain (22) .
Glucocorticoid effects are mediated through specific, ligand-dependent interactions with GR. After corticosteroid binding, GR influences transcription through distinct mechanisms that can involve direct DNA binding (23, 24) and/or protein-protein interactions (25) (26) (27) . For example, at the osteocalcin promoter GR binds a GRE that overlaps the binding site for TATA box-binding protein, and GR-DNA binding reduces transcription by preventing the binding of a basal transcription factor (28, 29) . Within the model of composite regulation, GR interacts with other transcription factors at adjacent or overlapping DNAregulatory elements (30, 31) . Several examples of composite regulation between GR and AP-1 nucleoproteins (c-jun and c-fos) have been observed (31, 32) . In this setting, the transcriptional effect of liganded GR may be influenced by cell-specific factors as well as relative concentrations of c-jun and c-fos (31) . In addition, hormonal repression may occur through mechanisms that do not require direct DNA binding of GR at specific target genes, but rather involve soluble interaction between GR and regulatory proteins such as AP-1 family members or NF-B (33, 34) . In addition, GR interacts with several functionally important coadaptors, including CREB-binding protein (CBP) and GR-interacting protein (GRIP-1) (35) (36) (37) .
In an effort to better understand potential mechanisms involved in glucocorticoid-dependent repression of CRH, we have attempted to specifically localize cis-acting region(s) of the CRH promoter critical for hormonal repression. The mouse corticotroph AtT-20 cell line is a useful in vitro model for repression of CRH, since glucocorticoids repress transcription of the endogenous POMC gene as well as exogenous CRH promoter introduced by either stable or transient transfection. Using a series of CRH promoter-luciferase constructs, we have previously reported that nested deletion of the CRH promoter (from Ϫ278 to Ϫ249 nt) results in complete loss of glucocorticoiddependent repression of cAMP-stimulated CRH promoter activity (15) . Analysis of this highly conserved sequence between Ϫ278 and Ϫ249 nt demonstrated the presence of potential glucocorticoid and AP-1 response element motifs, suggesting that direct DNA binding of both GR and AP-1 nucleoproteins may play a role in regulation of CRH promoter activity. Our objectives in the present series of studies were 1) to further localize the negative glucocorticoid response element (nGRE); 2) to characterize protein-DNA interactions involving GR and AP-1 nucleoproteins at this site; and 3) to assess the functional role of putative GR and AP-1 binding sites within this element in the context of both intact CRH and heterologous promoter constructs. Our results establish that the nGRE plays an important role in hormonal activation mediated by both cAMP and AP-1 nucleoproteins and also mediates glucocorticoid-dependent repression. Further, promoter mutations that interrupt either AP-1 or GR binding activity to the nGRE lead to abrogation of glucocorticoid-dependent repression, suggesting that interactions between GR and AP-1 or related nucleoproteins may mediate hormonal repression at this regulatory element.
RESULTS

Nested Deletions of the hCRH Promoter Localize a nGRE between ؊278 and ؊249 nt
In previous studies, nested deletions to Ϫ278 nt retained cAMP-dependent activation and dexamethasone (DEX)-dependent repression while DEX-dependent repression was eliminated when CRH promoter constructs were shortened to Ϫ249 nt (15) . Additional CRH promoter deletion constructs were used to confirm and further localize putative nGRE site(s) mediating hormonal repression (Fig. 1) . As previously shown, glucocorticoiddependent repression was retained in constructs containing sequences to Ϫ278 nt, while deletion to Ϫ249 nt completely eliminated DEX-dependent repression. Two deletions that disrupt the region between Ϫ278 and Ϫ249 nt [CRH(Ϫ270)luc and CRH(Ϫ260)luc] retained partial glucocorticoid-dependent repression. As expected, cAMP responsiveness was retained in all constructs containing the cAMP-response element (CRE) at Ϫ224 nt (data not shown). Loss of DEX-dependent repression with preservation of cAMP responsiveness in both CRH(Ϫ249)luc and CRH(Ϫ235)luc indicates that glucocorticoids do not repress CRH promoter activity through interference with the CRE or CRE-binding proteins. This result is in contrast to the findings of Guardiola-Diaz et al. (16) who reported colocalization of a glucocorticoid-dependent repression to the CRE (see Discussion).
The region between Ϫ278 and Ϫ249 nt is highly conserved, with 100% homology between rat, ovine, and human genes. Analysis of this sequence identified three sites with GRE half-site homology (Fig. 2B) . In contrast to consensus GRE sites that support GR dimer formation and are in palindromic orientation ( Fig. 2A) , the GRE half-sites of the CRH gene are organized as direct or inverted repeats. In addition, two sites having homology with consensus AP-1 response elements (Fig. 2C) were identified within the functionally defined nGRE (Fig. 2B) . For subsequent AtT-20 cells were transfected with hCRH promoter-luciferase reporter constructs by calcium phosphate precipitation as described in Materials and Methods. Data (mean Ϯ SEM of at least three independent experiments) are expressed as the percentage of 8-Br-cAMP-stimulated promoter activity observed with 8-Br-cAMP and DEX cotreatment; therefore, no repression is 100%. Nested deletions are designated by the most 5Ј nt of the hCRH promoter retained. * Indicates significant DEX-dependent repression. ᭜ Indicates significantly less repression than CRH(Ϫ918)luc. Nested deletion constructs containing an intact nGRE (constructs extending upstream of Ϫ278 nt) demonstrated approximately a 2-fold DEX-dependent repression of cAMP-stimulated promoter activity (ϳ50% of 8-Br-cAMP stimulated). Nested deletions that eliminated the entire nGRE (CRH(Ϫ249)luc, CRH(Ϫ235)luc, CRH(Ϫ200)luc) demonstrated no DEX-dependent repression. Nested deletions that disrupted the nGRE (CRH(Ϫ270)luc, CRH(Ϫ260)luc) demonstrated significant, but reduced, glucocorticoid repression of cAMP-stimulated CRH promoter activity. This region of the hCRH promoter has 100% homology with rat and ovine CRH genes. Sites with GRE half-site homology are shown on the top (sense) strand and have either 4/6 (GR-sites 1 and 3) or 5/6 (GR-site 2) similarity with the GRE half-site consensus (5Ј-TGTACA-3Ј) sequence. Sites with AP-1 site homology are shown on the bottom (antisense) strand; AP1-site 1 has 6/7 similarity with the nonclassical AP-1 site of the composite GRE of the mouse proliferin gene (30) , while AP1-site 2 has 5/7 similarity with the consensus AP-1 element (5Ј-TGACTCA-3Ј). For mutant probes used in EMSA and mutant constructs used in transient transfection assays, putative transcription factor binding sites were mutated to EcoRI restriction sites (5Ј-GAATTC-3Ј). Specifically, GR binding site mutants were designated mut1 to mut3 with respect to GR sites 1-3 shown in panel B (e.g. mut2 indicates mutation of GR-site2). Mutation of GR binding sites in functional constructs was similarly designated (e.g. ⌬GRsite2 indicates mutation of GR-site2).
binding and functional studies, putative GR binding sites 1-3 and putative AP-1 binding sites 1 and 2 refer to upstream and downstream elements indicated in Fig. 2B (see Materials and Methods).
Localization of GR Binding to the CRH nGRE
Ligand-bound GR can influence transcription by direct DNA binding to regulatory sequences (28, 31, 38, 39) or through protein-protein interactions involving GR and other transcription factors and/or coadaptors (31, 33, 40, 41) . To better define the role of GR-DNA binding, we sought to characterize and localize high-affinity GR interactions with the CRH nGRE sequence. Electrophoretic mobility shift assays (EMSAs) were performed using bacterially expressed rat GR DNAbinding domain (GR-DBD, kindly provided by L. Freedman, Sloan-Kettering Institute, New York, NY) (42) and wild-type or mutant CRH nGRE probe (Fig. 3) . As expected, GR-DBD specifically bound a positive control probe containing the GRE from the mouse mammary tumor virus (MMTV) at two sites and, as previously described, interacted with the CRH nGRE probe (CRH, Ϫ278 to Ϫ249 nt) at two sites (15) . In contrast, GR-DBD failed to shift the negative control CRE probe (CRH, Ϫ220 to Ϫ228 nt). GR-DBD bound MMTV and CRH probes with similar affinities (see Table 1 ); however, at the same protein concentration (20 ng), GR-DBD interacted with MMTV to yield a protein-DNA complex consistent with dimeric binding, while GR-DBD interactions at the CRH nGRE produced a complex consistent with predominantly monomeric GR-DBD binding. Interestingly, at higher GR-DBD concentrations a second, higher mol wt band appeared that is consistent with GR-DBD binding at two sites within the CRH nGRE probe (15) .
To determine which potential GRE half-sites participate in high-affinity GR-DBD binding, we introduced mutations into upstream, middle, or downstream GRE sequences (designated mut1, mut2, and mut 3, respectively) and examined GR binding using EMSA (Fig. 3 , data summarized in Table 1 ). Mutation of the middle GRE to an EcoRI site (Fig. 3, mut2 ) resulted in a 10-fold reduction in the affinity (k d ) of GR-DBD for the probe and a commensurate reduction in percentage of two-site GR-DBD binding. In contrast, mutation of the upstream or downstream GR binding sites (mut1, mut3) reduced k d by 2-fold and dimer formation by 4-fold. This identifies the middle GR binding site as the high-affinity GR binding site within the functionally defined nGRE. These data are supported by studies of nGRE probes containing mutations at two GR binding sites. Mutation of GR-sites 1 and 2 (mut1,2) markedly reduced GR-DBD affinity for the nGRE, while a less dramatic reduction in affinity was observed when the middle GR binding site was preserved (mut1, 3). As expected, mutation of all three GR binding sites (mut1,2,3) eliminated detectable GR-DBD binding. The high-affinity GR binding site identified in these EMSA experiments corresponds to the same region of the CRH promoter in which high-affinity GR binding was identified by deoxyribonuclease I (DNase I) footprinting (16) . Labeled probes were incubated in the absence or presence of 5 ng of rat GR-DBD (amino acids 440-525) and separated by nondenaturing PAGE. MMTV probe contains a classical consensus GRE sequence (5Ј-GTTACAnnnTGT-TCT-3Ј). CRE probe contains the palindromic cAMP response element (5Ј-GTCATGAC-3Ј). CRH probe contains the nGRE of hCRH (Ϫ278 to Ϫ249 nt) shown in Fig. 2 . mut 1 to mut 1,2,3 are CRH nGRE probes containing EcoRI restriction sites in place of putative GR binding sites designated in Fig.  2 . Protein-DNA complexes consistent with GR-DBD monomeric and dimeric binding are designated on the basis of migration patterns observed in previously described gel-shift studies of the MMTV GRE (64) . Mutation of the middle GR binding site (mut2) reduced affinity and dimer formation more than mutation of either or both outside GR binding sites (mut1, mut3, and mut1, 3). Negative control probes, mut1,2,3, and CRE did not demonstrate a band shift in the presence of GR-DBD. Affinity and dimer formation data are summarized in Table 1 . P-labeled probe with increasing amounts of GR-DBD (64) . Percent dimer was calculated by dividing the signal of the dimer band by the combined signal of all shifted probe (monomer ϩ dimer) at 20 ng GR-DBD. Signals were quantitated using ImageQuant software (Molecular Dynamics, Inc.). nd, Not determined (i.e. band signals not greater than background).
AP-1 Interactions within the CRH nGRE
EMSA was also used to evaluate binding of purified, bacterially expressed AP-1 proteins at putative AP-1 sites within the CRH nGRE. As shown in Fig. 4A , probes containing either the consensus AP-1 binding site of the collagenase promoter (5Ј-TGACTCA-3Ј) or the CRH nGRE interacted with AP-1 proteins as jun:jun homodimers and jun:fos heterodimers. Mutation of the upstream AP-1 binding site to an EcoRI site (AP1-mut1) had little effect on AP-1 binding, while mutation of the downstream putative AP-1 binding site (AP1-mut2), markedly reduced both jun: jun and jun:fos binding in vitro. These findings indicate that the downstream AP-1 element (Fig. 2 , AP1-site 2) represents the high-affinity AP-1 binding site within the nGRE. AP-1 binding activity was confirmed by cross-competition studies (data not shown). In these studies, excess unlabeled CRH, colAP1, or AP1-mut1 probes effectively competed for AP-1 binding to labeled CRH or colAP1 probes. In contrast, excess unlabeled AP1-mut2 probe (CRH probe containing a mutated downstream AP-1 site) failed to compete for AP-1 binding at either of these probes. Interestingly, mutation of the upstream AP-1 site (AP1-mut1) somewhat reduced GR-DBD binding to the CRH nGRE, while mutation of the downstream AP1-site (AP1-mut2) did not (Fig. 4A ). Since the AP1-mut1 mutation also disrupts the distal GRE half-site, decreased GR-DBD dimer formation suggests that this half-site participates in GR-DBD dimerization at the nGRE. That AP-1 binding was preserved with mutation of the high-affinity GR binding site (Fig. 4B) indicates that GR and AP-1 binding activities can be experimentally distinguished through selective mutation of binding sites.
Internal Deletions and Discrete Mutations within the Intact CRH Promoter
Analysis of nested deletions may be complicated by the serial removal of upstream sequences that influence defined regulatory elements through additive or synergistic interactions. Thus, additional transfection studies using constructs containing internal deletions or discrete mutations of the nGRE (Ϫ278 to Ϫ249 nt) were performed to further define the functional role of the nGRE within the context of the intact CRH promoter (to Ϫ918 nt). As shown in Fig. 5 , internal deletion of the entire nGRE (CRH(Ϫ918)[⌬278-249]luc) significantly reduced, but did not eliminate, DEX-dependent repression relative to the wild-type CRH promoter. This confirms an important functional role for sequences between Ϫ278 and Ϫ249 nt, but suggests that additional upstream sites may participate in glucocorticoid-dependent repression. In an effort to localize secondary glucocorticoid-responsive elements, we extended the internal deletion to include additional 5Ј-regulatory sequences from (CRH(Ϫ918)[⌬295-249]luc and CRH(Ϫ918)[⌬340-249]luc). Both of these constructs retained partial glucocorticoid-dependent repression that was not different from the more limited nGRE internal deletion construct (CRH(Ϫ918) [⌬278-249]luc). Thus, it appears that CRH promoter se- A, Labeled probes were incubated with either 10 ng c-jun and 10 ng c-fos (JF) or 20 ng c-jun (J) or 20 ng GR-DBD (GR), separated by 6% PAGE, and visualized using a PhosphorImager (Molecular Dynamics, Inc.). The colAP-1 probe contains the consensus AP-1 site of the collagenase promoter (Ϫ73 to Ϫ66 nt, 5Ј-TGACTCA-3Ј). The CRH probe contains the hCRH nGRE (Ϫ278 to Ϫ249 nt) shown in Fig. 2B . The AP1-mut1 and AP1-mut2 are CRH nGRE probes containing EcoRI restriction sites at the putative AP-1 sites designated in Fig. 2B . GR-DBD monomer and dimer bands are designated with respect to intact CRH probe. AP-1 hetero-and homodimer bands are designated with respect to the colAP1-positive control. Mutation of the 3Ј AP-1 binding site (AP1-mut2), but not the 5Ј AP-1 site (AP1-mut1) decreased AP-1 binding to the CRH nGRE. B, A CRH probe containing a mutation of the high-affinity GR binding site (GR-mut2, see Fig. 2 ) retains the ability to bind AP-1 proteins. Reactions are as described for panel A.
quences between Ϫ340 and Ϫ918 nt contribute to glucocorticoid-dependent regulation in a manner independent of the nGRE between Ϫ278 to Ϫ249 nt.
We also examined the effects of specific mutations of GR-and AP-1 binding sites within the context of the CRH promoter (Fig. 5) . Mutation of all three GR binding sites (CRH(Ϫ918)[⌬GRsites1,2,3]luc) reduced glucocorticoid-dependent repression by approximately 50%. Similar reductions in glucocorticoid-dependent repression were seen when only the high-affinity GR binding site was mutated (CRH(Ϫ918)[⌬GRsite2]luc, which corresponds to the mut2 probe in Fig. 3 ). This confirms the functional importance of the highaffinity GR binding site defined by EMSA. Interestingly, mutation of the high-affinity AP-1 binding site (CRH(Ϫ918)[⌬AP1 site2]luc, which corresponds to the AP1-mut2 probe in Fig. 3 ) also decreased glucocorticoid-dependent repression relative to the wild-type CRH promoter. Since this mutation does not interfere with GR-DBD binding (Fig. 4A) , the decreased DEXdependent repression associated with this mutation suggests a specific role for AP-1 binding in hormonal regulation.
The possibility of interactions between GR-and CRE-binding proteins or their cognate coadaptors is also of interest, since GR is capable of physical interactions with CREB (43) and can repress cAMP-stimulated promoter activity through interference with mutually required cofactors (40, 44) . Furthermore, within the CRH promoter, Guardiola-Diaz et al. localized glucocorticoid-dependent repression and cAMP stimulation to the CRE (16) . Experiments summarized in Fig.  6 specifically examine the regulatory relationship between nGRE and CRE sequences within the CRH promoter. As previously reported, internal deletion of the CRE (CRH(Ϫ918)[⌬CRE]luc) significantly reduced cAMP-dependent activation relative to the intact promoter but did not interfere with hormonal repression (15) . Similarly, internal deletion of the CRE in the context of CRH(Ϫ249)luc also reduced cAMP activation relative to the parent construct. Interestingly, internal deletion of the high affinity AP-1 site (CRH(Ϫ918)[⌬A P1site2]luc) significantly reduced cAMP responsiveness, suggesting either that the high-affinity AP-1 site of the nGRE functions as a secondary CRE or that the AP-1 and CRE interact synergistically. As expected, constructs lacking a defined CRE, including CRH(Ϫ200)luc, CRH(Ϫ38)luc, and ␣hCG(Ϫ100)luc, demonstrated only mild (ϳ1.5 fold) nonspecific cAMP induction that was not repressible by glucocorticoids.
The nGRE and CRE Confer Transcriptional Regulation to a Heterologous Promoter
Many enhancer and repressor elements confer signaldependent regulation to a heterologous promoter. To examine regulation in a heterologous context, defined regulatory elements were placed upstream of the minimal Drosophila alcohol dehydrogenase (Adh) promoter, and hormonal regulation of these constructs was examined in transfected AtT-20 cells (Fig. 7) . The basal Adh promoter demonstrated no hormonal regulation; however, CRH promoter fragments that included both CRE and nGRE sequences (CRH[Ϫ285 to Ϫ90])Adh and CRH[Ϫ285 to Ϫ160]Adh) conferred both cAMP-dependent stimulation and DEX-dependent repression to the Adh promoter. Studies of the CRE and nGRE in isolation confirm the structural independence of these elements. One or three copies of the CRE (1ϫ CRH CRE-Adh and 3ϫ CRH CRE-Adh) conferred cAMP-dependent induction but not DEXdependent repression to the Adh promoter. In contrast, the nGRE (1ϫ CRH nGRE-Adh and 3ϫ CRH nGRE-Adh) conferred mild cAMP responsiveness as well as glucocorticoid-dependent repression to the Adh promoter, consistent with the function of this element as both a nGRE and secondary CRE.
In addition, we examined cAMP and glucocorticoid effects on an additional construct containing three copies of composite GRE from the mouse proliferin promoter [3ϫ PLF cGRE-Adh also called PLFG3.1 (31) ]. This element contains both GR and AP-1 responsive elements upstream of the heterologous Adh promoter. As indicated in Fig. 7 , the PLF cGRE conferred both cAMP-and glucocorticoid-dependent regulation to the Adh promoter. Thus, it appears that cAMP is capable of stimulating transcriptional activation through AP-1 responsive elements in the context of AtT-20 cells. It is unclear whether this effect is mediated through changes in AP-1 nucleoprotein levels, phosphorylation status, or through phosphorylation of nucleoproteins more classically associated with protein kinase A (PKA)-dependent activation pathway, such as CREB or ATF-1.
The nGRE and CRE Regulate Basal Promoter Activity
Many hormonally responsive elements influence the rate of basal transcription. We observed that both the high-affinity AP-1 site within the nGRE and the consensus CRE influenced basal CRH promoter activity ( Table 2 ). Mutations that replaced the high-affinity AP-1 or disrupted the CRE both decreased basal transcription, suggesting that both of these elements influence transcription in the absence of cAMP. This conclusion was supported by parallel experiments using the heterologous Adh promoter. Relative to the minimal Adh promoter, one or three copies of the CRE dramatically augmented basal transcription. Similarly, one or three copies of the nGRE (Ϫ278 to Ϫ249 nt) placed upstream of the heterologous Adh promoter produced a 3-to 6-fold increase in basal transcription. The cGRE from the proliferin gene produced a similar increase in basal transcription.
The CRH nGRE Represents a Functional AP-1 Site
To assess the functionality of AP-1 sites identified by sequence analysis and in vitro binding studies, we performed transient expression studies in which relative levels of c-jun and c-fos were manipulated by cotransfection of AP-1 expression plasmids (Fig. 8) . Transfection of the c-jun expression plasmid induced the transcriptional activity of the intact CRH promoter by 9-fold. This induction was repressible by glucocorticoids. In contrast, overexpression of c-fos produced less dramatic induction of CRH that was minimally inhibited by DEX. A different pattern of AP-1 activation and glucocorticoid-dependent repression was obtained when the nGRE was examined in the context of the heterologous Adh promoter. In this context, c-fos produced a greater magnitude of induction than c-jun (22-fold vs. 8-fold), and conditions of jun or fos excess were both sensitive to DEX-dependent repression. Two control plasmids were also evaluated. The composite element from the proliferin gene was activated by both jun and fos, and DEX effectively inhibited AtT-20 cells were transfected as described in Materials and Methods, except reporter concentration was increased to 5 g/plate to facilitate analysis of basal promoter activity (see Table 2A activation under conditions of c-jun excess. In contrast, the CRE was minimally responsive to overexpressed AP-1 proteins and was not DEX repressible under any conditions tested.
Role of High-Affinity GR-and AP-1 Binding Sites in Stimulation and Repression
High-affinity GR-and AP-1 binding sites were mutated to EcoRI sites in the context of the 3ϫ CRH nGRE-Adh construct to specifically assess the role of these sites in cAMP-dependent induction, AP-1 dependent induction, and DEX-dependent repression. As shown in Fig. 9A , mutation of either the high-affinity GR binding site or the high-affinity AP-1 site significantly decreased the magnitude of cAMPdependent induction relative to the intact nGRE. In addition, both mutations led to complete loss of glucocorticoid repression of cAMP-stimulated activity. Stimulation by AP-1 proteins and glucocorticoid repression of this activity were also examined using these mutant constructs. As shown in Fig. 9B , mutation of high-affinity GR or AP-1 sites had no effect on c-jun-mediated induction but decreased c-fos-
Fig. 7. The CRE and nGRE Regulate a Heterologous Promoter
Hormonal regulation of various regulatory elements was examined in transfected AtT-20 cells. Data are expressed as in Fig. 6 . Regulatory elements were inserted into the PstI/SalI sites upstream of the Adh promoter as described in Materials and Methods. All constructs except the basal Adh promoter demonstrated significant cAMP stimulation. CRH(Ϫ285 to Ϫ90)-Adh and CRH(Ϫ285 to Ϫ160)-Adh contain both the nGRE and CRE sequences and thus conveyed both cAMP and DEX responsiveness to Adh. 1ϫ CRH CRE-Adh and 3ϫ CRH CRE-Adh contain one and three copies, respectively, of the CRH CRE (Ϫ231 to Ϫ219 nt) and conveyed only cAMP responsiveness to Adh. 1ϫ CRH nGRE-Adh and 3ϫ CRH nGRE-Adh contain one and three copies, respectively, of the CRH nGRE (Ϫ278 to Ϫ249 nt) and conveyed DEX-dependent repression and mild cAMP responsiveness to Adh. 3ϫ PLF cGRE-Adh contains three copies of the proliferin promoter cGRE [Ϫ254 to Ϫ230 nt, PLFG3.1 (31)] and also conveyed mild cAMP induction and DEX-dependent repression to Adh. * Indicates significant DEX-dependent repression. ᭜ Indicates reduced DEX-dependent repression compared with 3ϫ CRH nGRE-Adh. ᭜᭜ Indicates increased cAMP induction compared with 1ϫ CRH CRE-Adh. mediated induction. Interestingly, glucocorticoiddependent repression of AP-1-stimulated activity was preserved, suggesting that, at this element, repression of both cAMP activation and AP-1 activation is mediated through distinct mechanisms.
CREB Interactions at the CRH nGRE
AP-1 elements can mediate induction by CREB family members (45, 46) , and cAMP modestly activates the CRH nGRE (Fig. 9A) . Thus, we studied the role of CREB at the CRH nGRE in using cotransfection of plasmids that express either full-length CREB (CREB-FL) or a dominant negative truncated CREB (CREB-BR) capable of binding DNA but lacking the transactivation domain (47) . As shown in Fig. 10A , CRH nGRE and CRH CRE were induced by 8-Br-cAMP, and this induction was reduced by cotransfection of CREB-BR. Furthermore, overexpression of full-length CREB stimulated activity at each of these elements in a noncAMP-dependent manner (Fig. 10A) . The nGRE was unexpectedly more sensitive to overexpressed CREB (ϳ40-fold induction) than classical CRE (ϳ5-fold induction, P Ͻ 0.05). This stimulation appears to be mediated by the high-affinity AP-1 site, since mutation of this site (3ϫ CRH nGRE ⌬AP-1 site 2) abrogated stimulation by both cAMP and CREB. Transcriptional activation mediated by CREB and cAMP was clearly due to enhancer elements contained within the nGRE, as no stimulation was observed at the basal Adh promoter. Interestingly, CREB-stimulated activity at the CRH nGRE or CRH CRE was not repressed by glucocorticoids (Fig. 10B) .
DISCUSSION
While intracellular signaling events leading to activation of gene transcription by glucocorticoids are relatively well understood, many important biological effects of corticosteroids are mediated through repression of specific gene transcription and involve complex, distinct mechanisms of transcriptional regulation that are cell-and promoter-specific (48) . The CRH gene is of particular interest as a model for glucocorticoid-dependent repression, since it is a physiologically relevant target of corticosteroids and a critical component of long-loop feedback regulation of the HPA axis (3, 22) . Although the corticotroph-derived AtT-20 cell line used in this series of transient transfection experiments is not a site of endogenous CRH expression (49) , it represents a parallel limb of physiological corticosteroid feedback regulation and has been used in several independent laboratories to investigate glucocorticoid-dependent repression of CRH. The present study accomplishes the following: 1) a cis-acting site of the CRH promoter that mediates negative regulation by glucocorticoids was precisely localized; 2) the functional role of this element was defined in the context of both intact CRH and heterologous Adh promoters; 3) the sites and affinities of GR and AP-1 binding within the functionally defined nGRE were determined; and 4) the nGRE was established as a site that can mediate transcriptional activation by both cAMP and AP-1 proteins as well as transcriptional repression by glucocorticoids. Together these results suggest that glucocorticoids inhibit CRH gene transcription through a mechanism that involves direct binding of GR, as well as AP-1 or related nucleoproteins, to be defined cis-acting element of the CRH promoter.
Although the proximal 1 kb of the CRH promoter confers glucocorticoid-dependent regulation to various reporter genes (16, 50) , the localization of cisacting elements within the CRH promoter and potential mechanism of glucocorticoid-dependent repression remain uncertain. Sequence analysis demonstrates remarkable conservation between species within the proximal promoter of the CRH gene (Ͼ90% between rat, ovine, and human genes between Ϫ300 and ϩ1), suggesting an important role for functional elements contained within this region. Although no classical consensus GRE sequences have been identified within the CRH promoter, Guardiola-Diaz et al. demonstrated several regions of high-affinity GR binding using rat GR DNA-binding domain in a DNase I protection assay (16) . Indeed, the functional nGRE localized in our study corresponds precisely to one of these sites. Interestingly, Guardiola-Diaz et al. observed that glucocorticoid-dependent repression was maintained in the plasmid CRH(Ϫ249)CAT (16), while we observed loss of repression in an equivalent luciferase-based construct (CRH(Ϫ249)luc, see Fig. 6 ). In AtT-20 cells were cotransfected with the indicated reporter (2 g), expression vectors for c-jun or c-fos (4 g), and expression vector for GR␣ (2 g). Cells were then treated, harvested, and assayed as described in Materials and Methods; data (mean Ϯ SEM of at least three independent experiments) are expressed as fold induction. All constructs demonstrated significant (P Ͻ 0.05) induction with overexpressed c-jun or c-fos except 3ϫ CRH CREAdh, which did not induce with c-jun. ᭜ Indicates significant DEX-dependent repression of c-jun-or c-fos-stimulated promoter activity.
addition, Guardiola-Diaz et al. reported suppression of heterologous construct containing the CRE linked to an SV40 promoter (16) . In contrast, we observed no repression when the CRE was linked to a heterologous Adh promoter and both cAMP-dependent induction and glucocorticoid-dependent repression when the nGRE (Ϫ278 to Ϫ249) was placed upstream of this same promoter (Fig. 7) .
The experimental basis for these disparate results is uncertain. Results obtained in the present study, including evaluation of the nGRE through additional nested and internal deletion constructs as well as heterologous contexts, clearly establish the localization and reproducibility of the nGRE under experimental conditions used in our laboratory. A possible explanation for these different results may be related to the presence of a cryptic AP-1 site in the puc18 plasmid backbone used in the aforementioned study (16) , which is absent in the pBR-based backbone used in the present series of experiments. The potential for artifactual glucocorticoid repression in the pUC18-derived plasmid containing enhancer elements has been previously reported (51) and would explain the apparent glucocorticoid repression observed in CRH or heterologous promoter constructs containing the CRE reported by Guardiola-Diaz et al. (16) . However, unpublished data indicate a similar pattern of glucocorticoid-dependent repression is observed for these constructs when the cryptic AP-1 site is deleted (S. Coon and A. Seasholtz, personal communication). An alternative possibility is that differences in the host AtT-20 cell line may account for different regulatory effects. Since CRH is not expressed in the corticotroph and its regulation in AtT-20 cells is of interest primarily as a model system, mechanisms of glucocorticoid-dependent repression defined by the Seasholtz laboratory (16) and in the present experiments are both of heuristic interest. Clearly, it will be important to determine which potential cis-acting element(s) and mechanisms defined by in vitro studies of the CRH promoter are critical in glucocorticoid repression of hypothalamic CRH expression in situ.
Our observation that internal deletion of the nGRE in the context of the intact CRH promoter partially reduced glucocorticoid-dependent repression suggests that upstream sequences within the CRH promoter also contribute to transcriptional repression. Glucocorticoid repression in constructs containing internal deletions of the nGRE and surrounding sequences is specific, since neither constitutive nor cAMPresponsive control promoters demonstrate DEX-dependent repression. In an effort to localize potential regions of the CRH promoter that contribute to hormonal repression independent of the nGRE, we extended the internal deletion nGRE to include additional upstream sequences. However, both CRH⌬(Ϫ295/ Ϫ249) and CRH⌬(Ϫ340/Ϫ249) demonstrated a magnitude of DEX-dependent repression comparable to the more limited nGRE deletion (CRH⌬(Ϫ278/Ϫ249)). These results suggest that a previously identified GR binding site between Ϫ313 and Ϫ301 (16) does not represent a functional nGRE, and that additional hormonally responsive element(s) are located upstream of Ϫ340 nt.
Mechanisms of glucocorticoid-mediated repression can be broadly divided into those that require direct GR binding to the target gene promoter (e.g. occlusion, composite regulation) and those that act without DNA binding (e.g. soluble interactions, cross-repression, squelching). Our gel-shift results demonstrating high-affinity GR binding at the middle GRE half-site confirm the DNase I protection results of GuardiolaDiaz et al. (16) . A mechanism of glucocorticoid-dependent repression that requires direct DNA binding is supported by the observation that mutations that disrupt GR binding activity at this site reduce hormonal repression (Fig. 5) . This is consistent with previous studies of Majzoub and co-workers (50), who observed that GR mutants lacking DNA-binding activity fail to repress CRH gene expression.
GR typically interacts as a dimer at "simple" or activating GREs (52) . Within negatively regulated promoters, dimeric GR binding has been observed at the proliferin composite GRE (31), while trimeric GR-DNA interactions have been observed at the POMC gene (38) . Within the CRH nGRE, the high-affinity GRE halfsite is flanked by two lower affinity GRE half-sites, suggesting that GR interacts as a dimer or trimer at this site. However, the classic palindromic GRE organization that supports dimeric GR binding is not present within the CRH nGRE (Fig. 2) . At higher concentrations of GR-DBD, we have observed GR-DNA interactions at the lower affinity GRE half-sites (15). However, because our studies used the DNA-binding domain rather than full-length GR, it is unclear whether this element would support homodimeric binding of full-length GR.
Several examples of glucocorticoid-dependent regulation involve interactions between GR and members of the basic leucine zipper superfamily (e.g. AP-1 and CREB/ATF family members (31, 40, 53) . Our results establish that the proximal AP-1 sequence within the CRH nGRE is capable of specific and high-affinity interactions with both jun:jun homo-and jun:fos heterodimers. Furthermore, the functional activity mediated through the proximal AP-1 element in response to both cAMP and overexpressed AP-1 proteins establish that AP-1 binding activity is associated with transcriptional activation. The magnitude of transcriptional activation produced by overexpression of c-jun and c-fos, respectively, differed between intact CRH and minimal heterologous promoters. This may be related to the presence of other functional AP-1-responsive elements within the CRH promoter (54) or to endogenous expression of AP-1 family members within AtT-20 corticotrophs.
In addition to mediating activation in response to overexpressed AP-1 nucleoproteins, we found that the nGRE functions as a cAMP-response element independent of the CRE at Ϫ224 nt. When examined in a heterologous context, the consensus CRE increased both basal and cAMP-stimulated transcription more than the nGRE. However, within the context of the intact CRH promoter, internal deletion of either element produced a similar decrement in cAMP response. The mechanism of cAMP-dependent activation through the nGRE is uncertain. One possibility is that cAMP acts through a classical PKA-dependent pathway to stimulate phosphorylation of CREB, ATF-1, or related nucleoproteins. CREB and related nucleoproteins are capable of binding some AP-1 response elements and may lead to either transcriptional activation or repression in a cell-and promoterspecific fashion (45, 55, 56) . In addition, CREB/ATF and AP-1 family members may heterodimerize at certain CRE and/or AP-1 elements (55, 57, 58) . The ability of a dominant negative CREB mutant that lacks the transcriptional activation domain but retains DNAbinding activity to suppress the cAMP response mediated through the nGRE suggests that CREB is capable of interacting at the CRH nGRE. Another possibility is that cAMP acts through PKA-dependent transcriptional effects leading to changes in the absolute or relative concentrations of c-jun or c-fos. Another hypothesis is that synergy exists between nucleoproteins interacting at nGRE (AP-1) and CRE sites. In this model, synergistic nucleoprotein interactions could contribute to cAMP-dependent activation mediated through the nGRE, and liganded GR could disrupt these interactions to produce glucocorticoid-dependent repression. Alternatively, PKA stimulation may influence other signal transduction elements, like mitogen/stress-activated kinases that regulate phosphorylation-dependent activation of CREB, as well as activation of AP-1 response elements in several neuronal and endocrine cell types (59) (60) (61) (62) .
The localization of GR and AP-1 binding within a single regulatory element, coupled with the loss of hormonal repression observed after mutation of either site, suggests that the CRH nGRE functions as a composite regulatory element. This conclusion is supported by the observation that hormonal regulation of the CRH nGRE parallels that of the well characterized composite element from the mouse proliferin gene. In addition, the CRH nGRE has a complex structure similar to that of the previously described composite GREs from the mouse proliferin and bovine PRL genes (31, 63) . The mechanism by which GR and AP-1 nucleoproteins interact at composite elements to activate or repress gene transcription in a tissue-specific fashion remains uncertain. While we did not examine co-occupancy of GR and AP-1 nucleoproteins at the nGRE, it is possible that GR binding may interfere with AP-1 binding or influence the composition of AP-1 nucleoproteins at this element. In addition, the role of coadaptors in mediating regulatory responses from composite elements has yet to be defined. One interesting possibility is that the host of transcription factors recruited to a composite element then determines the composition of the coadaptor complex and hence the signal transmitted to the basal transcription apparatus. Within this model, the ability of glucocorticoids to effect positive and negative regulation from a composite response element may be mediated through differential recruitment of coadaptors that facilitate regional histone acetylation and deacetylation. The cell specificity observed for directional regulation of composite glucocorticoid response elements may be influenced not only by relative concentrations and phosphorylation status of AP-1 and related nucleoproteins, but also the host cell repertoire of coactivator and corepressor proteins. In any case, it will be crucial to extend the current findings related to glucocorticoiddependent relation of the CRH promoter to other in vitro and in vivo models to better understand the molecular mechanisms of negative glucocorticoid feedback of the HPA axis.
MATERIALS AND METHODS
EMSA
EMSA was performed as previously described (15, 64) . Briefly, DNA probes were created by annealing complementary oligonucleotides designed with 5Ј-overhangs, labeled using the Klenow fragment of DNA polymerase, dNTPs, and [ 32 P](␣)dATP, and purified by chromatography over G50 Sephadex (Pharmacia Biotech, Uppsala, Sweden) and phenol-chloroform extraction. Probes with the following target sequences were prepared (consensus sequences shown in bold): MMTV GRE, containing the palindromic consensus GRE from mouse mammary tumor virus (sense, 5Ј-GTT-GGGTTACAAACTGTTCT-3Ј; antisense, 5-ЈTGGTTAGAA-CAGTTTGTAAC-3Ј); CRE, containing the 8-bp CRE present in the hCRH promoter at Ϫ224 nt (sense, 5Ј-GTTGGT-GACGTCA-3Ј; antisense, 5Ј-TGGTTTGACGTCA-3Ј); CRH, containing the nGRE from hCRH (Ϫ278 to Ϫ249 nt) (sense, 5Ј-ATTTTTGTCAATGGACAAGTCATA-3Ј; antisense, 5Ј-TT-CTTATGACTTGTCCATTGACA-3Ј); colAP1, containing the consensus AP-1 binding site from the collagenase promoter (Ϫ73 to Ϫ66 nt) (sense, 5Ј-GTTGGTGAGTCA-3Ј; antisense, 5Ј-GGTTGTGACTCA -3Ј). The upstream fragment was generated using a sense primer to the pA3luc backbone (pA3luc sense, 5Ј-CTGGATCCCCGGG-TACC-3Ј) and an antisense primer complementary to the region 5Ј of the desired deletion and containing a 5Ј-tail complementary to the region directly 3Ј of the desired deletion. The downstream fragment was generated using the PGL2 antisense primer and a sense primer complementary to the region 3Ј of the desired deletion and containing a 5Ј tail complementary to the region 5Ј of the desired deletion. After gel purification, firstround PCR products were denatured, allowed to anneal to each other, and then subjected to a second round of PCR using the outside primers (PGL2 and pA3luc sense ␣HCG(Ϫ100)luc (67) and expression vector for full-length CRE binding protein (CREB-FL, amino acids 1-327) were kindly provided by J. Hoeffler (Invitrogen). CREB-FL was placed under the control of the CMV promoter by ligation of the HindIII/XbaI fragment of CREB-FL into HindIII/XbaIdigested CMV4 vector (kindly provided by J. Omdahl, Department of Biochemistry and Molecular Biology, University of New Mexico Health Science Center). CMV-driven CREBbinding region (CREB-BR, amino acids 254-327) was created by BglII digestion of CMV-CREB-FL and religation of the digested product (47) . GR expression vector, pRSVhGR␣ (68), was kindly provided by R. Evans (Salk Institute, La Jolla, CA). Expression vectors for c-jun and c-fos were kindly provided by R. Tijan (University of California, Berkley, CA). p⌬ODLO (luciferase vector driven by a minimal Drosophila Adh promoter (Ϫ33 to ϩ53 nt) and PLFG3.1 (containing three copies of the composite GRE from the proliferin promoter in p⌬ODLO(31)) were kindly provided by K. Yamamoto (University of California, San Francisco, CA). Regulatory elements were inserted upstream of the minimal Adh promoter into PstI/SalI-digested p⌬ODLO using annealed pairs of complementary oligonucleotides designed to have PstI/SalI overhangs.
The following plasmids were created: [1ϫ nGRE]Adh, containing the nGRE of hCRH (Ϫ278 to Ϫ249 nt); [2ϫ nGRE]Adh, containing two copies of the nGRE of hCRH separated by a XhoI site; [1ϫ CRE]Adh, containing the CRE of hCRH (Ϫ231 to Ϫ217 nt); [3ϫ CRE]Adh, containing three copies of the CRE of hCRH; [3ϫ colAP1]Adh, containing three copies of the AP1 site of the collagenase promoter (Ϫ77 to Ϫ62 nt); [1ϫ nGRE-⌬GR site 2]Adh, containing the nGRE of hCRH in which the middle GR binding site has been mutated to an EcoRI site; [1ϫ nGRE-⌬AP1 site 2], containing the nGRE of hCRH in which the downstream AP-1 site has been mutated to an EcoRI site.
[3ϫ nGRE]Adh, containing three copies of the nGRE of hCRH, was created by inserting an annealed oligonucleotide pair containing the nGRE of hCRH with XhoI overhangs into the XhoI site of [2ϫ nGRE]Adh. [3ϫ nGRE-⌬GR site 2]Adh and [3ϫ nGRE-⌬AP1 site 2] were created by inserting an oligonucleotide pair containing two copies of the appropriate nGRE mutant with PstI/XhoI overhangs into the PstI and (engineered) XhoI sites of the 1ϫ parent construct.
[CRH(Ϫ285 to Ϫ90)]Adh and [CRH(Ϫ285 to Ϫ160)]Adh were generated by PCR of CRH(Ϫ918)luc template with 30 mer primers complementary to the appropriate regions of the CRH gene. The sense primer contained a 5Ј-PstI tail and the antisense primer contained a 5Ј-SalI tail. PCR-generated fragments were digested with PstI/SalI and inserted into PstI/ SalI-digested p⌬ODLO.
Cell Culture, Transfection, and Luciferase Assay
AtT-20 cells were maintained and transfected as previously described (22) . Briefly, AtT-20 cells were maintained under standard conditions in DMEM containing 10% FBS. Cells were transfected with CsCl 2 purified DNA at 70-80% confluence by calcium-phosphate precipitation with glycerol shock. Each 60-mm plate received 16 g DNA, consisting of 2-5 g luciferase reporter, 0-2 g GR expression vector, 0-4 g of expression vector for c-jun, c-fos, CMV-CREB-FL, or CMV-CREB-BR, and Bluescript KSϩ carrier to 16 g.
Statistical Analysis
Data are expressed as fold induction over a baseline level of 1.0 or as percentage of 8-Br-cAMP-stimulated promoter activity. Each experimental condition in all transfection experiments was performed in duplicate. The full-length CRH promoter construct (CRH[-918]luc) was included in each independent experiment as a positive control for cAMP induction and glucocorticoid repression. Pooled data represent the mean Ϯ SEM of at least three independent experiments. The number of independent experiments for plasmid CRH(Ϫ918)luc was 76; for other constructs the number of experiments ranged from 3 to 20. Overall statistical analysis was performed using repeated-measures ANOVA with posthoc pairwise comparison. Statistical significance of induction by 8-Br-cAMP, AP-1 proteins, or CREB-FL, and repression by DEX, was determined by paired Student's t test. Differences in hormonal responses between different reporter/receptor combinations were assessed by unpaired Student's t test. P Ͻ 0.05 was considered to be statistically significant.
